HCA Healthcare Flags Weak Surgical Volumes, Triggering Broad Medical‑Device Sell‑off
On 14 July 2026, Reuters reported that shares of major medical‑device manufacturers fell sharply after hospital operator HCA Healthcare (NYSE:HCA) released preliminary second‑quarter results indicating weaker‑than‑expected surgical procedure volumes. The article, authored by Louis Juricic, noted that the softening in surgical activity raised concerns about demand for medical‑device products and equipment across the healthcare sector.
The market reaction was pronounced: GE Healthcare (NASDAQ:GEHC) dropped 7 %, Intuitive Surgical (NASDAQ:ISRG) fell 6 %, Stryker (NYSE:SYK) slipped 5.4 %, Globus Medical (NYSE:GMED) slid 5.25 %, and Medtronic (NYSE:MDT) declined 4.7 %. Boston Scientific (NYSE:BSX), Baxter International (NYSE:BAX), and Tandem Diabetes (NASDAQ:TNDM) each fell about 4 %, while Zimmer Biomet (NYSE:ZBH) fell 3 % and Inspire Medical (NYSE:INSP) dropped 3.75 %.
Wells Fargo analyst Larry Biegelsen commented that he expects medical‑technology stocks to continue declining on the back of HCA’s results and anticipates the issue will be discussed during the companies’ second‑quarter earnings calls. Biegelsen highlighted that elective procedures—particularly orthopedic and spine surgeries—appear to be down mainly among patients under 65 years old, a group most exposed to the weakness. By contrast, non‑elective cardiovascular procedures performed on patients over 65 years old showed less weakness, providing a modest offset to the overall demand concerns.
The article concluded that the broad sell‑off across medical‑device manufacturers reflects investor anxiety that softer surgical volumes at hospitals could translate into reduced demand for their products in the coming quarters. The piece was generated with AI assistance and reviewed by an editor, with a note directing readers to the terms and conditions for further information.